Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects.
about
Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Randomized, placebo-controlled ...... S-986001, in healthy subjects.
@en
Randomized, placebo-controlled ...... S-986001, in healthy subjects.
@nl
type
label
Randomized, placebo-controlled ...... S-986001, in healthy subjects.
@en
Randomized, placebo-controlled ...... S-986001, in healthy subjects.
@nl
prefLabel
Randomized, placebo-controlled ...... S-986001, in healthy subjects.
@en
Randomized, placebo-controlled ...... S-986001, in healthy subjects.
@nl
P2093
P2860
P356
P1476
Randomized, placebo-controlled ...... S-986001, in healthy subjects.
@en
P2093
D Hawthorne
E Paintsil
H Sevinsky
P2860
P304
P356
10.1002/JCPH.252
P577
2014-01-17T00:00:00Z